Although it is anticipated that underdosing (inappropriate low dose) of factor Xa inhibitors will result in an elevated risk of stroke and other ischemic events, or overdosing (inappropriate high dose) is expected to increase the risk of bleeding events, the results of observational studies are conflicting [33]. The gene discussed is F10; the disease is stroke disorder.